市場調査レポート

世界の鎮痛剤市場

Analgesics

発行 Global Industry Analysts, Inc. 商品コード 138769
出版日 ページ情報 英文 767 Pages
納期: 即日から翌営業日
価格
こちらの商品の販売は終了いたしました。
Back to Top
世界の鎮痛剤市場 Analgesics
出版日: 2010年10月01日 ページ情報: 英文 767 Pages

当商品の販売は、2016年07月01日を持ちまして終了しました。

概要

当報告書では、鎮痛剤の製品開発および市場動向をめぐる最新情報や業界の課題などを検証しながら、各地域の動向と競合動向をまとめ、概略以下の構成でお届けします。

第1章 イントロダクション、方法論、製品の定義

第2章 世界の鎮痛剤市場概要

  • 痛み止め治療市場
  • 鎮痛剤市場 - 限りない発展性
  • 内服鎮痛薬
  • 外用鎮痛薬
  • 局所鎮痛剤市場
  • 競合シナリオ

第3章 製品概要

  • 概略史
  • 鎮痛剤の定義
  • 疼痛の種類
  • 急性疼痛
  • 慢性疼痛
  • 疼痛に効く薬剤
  • アスピリン
  • アセトアミノフェン
  • イブプロフェン、ケトプロフェン、ナプロキセン
  • OTC薬

第4章 業界動向

  • 高騰する研究開発費:恩恵か害悪か?
  • COX-2(シクロオキナーゼ - 2)危機が産業発展に影
  • オピオイド、非オピオイド療法を推進する新治療
  • 処方薬から市販薬への切り替え
  • 消費者が市販薬を好む理由
  • 鎮痛性トリペプチドの開発

第5章 近年の治験

第6章 製品導入・技術革新

第7章 近年の製品技術革新と上市

第8章 製品認可

第9章 近年の業界活動

第10章 近年の企業活動

第11章 主要参入企業

第12章 世界市場見通し

第13章 米国

第14章 カナダ

第15章 日本

第16章 欧州

  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン
  • その他

第17章 アジア太平洋地域

第18章 ラテンアメリカ

第19章 その他の諸国

第20章 付録:鎮痛剤の地域別著名ブランド

競合プロファイル:137社(事業部、子会社含め179社)

目次
Product Code: MCP-5064

Abstract

This report analyzes the worldwide markets for Analgesics in US$ Million by the following segments: Internal Analgesics, (Aspirin, Acetaminophen, Ibuprofen, and Others (includes combination drugs)), and External Analgesics. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2007 through 2015. A six-year historic analysis is also provided for these markets. The report profiles 137 companies including many key and niche players such as Bayer Consumer Care, Johnson & Johnson, McNeil Consumer Healthcare, Novartis International AG, Pfizer, Inc., Reckitt Benckiser Group Plc, and Sanofi Aventis S.A. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Table of Contents

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • 1. Internal Analgesics
      • Aspirin
      • Acetaminophen
      • Ibuprofen
      • Others
    • 2. External Analgesics

2. GLOBAL ANALGESICS MARKET OVERVIEW

  • Pain Therapeutic Market
  • Analgesics Market - Offering Immense Potential
  • Internal Analgesics - The Largest & Fastest Growing Market
    • Liquid Analgesics Register Rapid Growth
    • Neuropathic Pain - Unexplored
    • Ibuprofen Scoring High
  • External Analgesics - Loosing Sheen
  • Topical Analgesics Market: Current Picture
  • Competitive Scenario
    • Global Analgesics Market (2007): Leading Analgesics
      • Brands by Manufacturer

3. PRODUCT OVERVIEW

  • A Brief History
  • Analgesics
    • Definition
  • Types of Pain
  • Acute Pain
  • Chronic Pain
  • Drugs Combating Pain
    • Local Anesthetics
    • Narcotic Opioids
    • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
      • Types of NSAIDS
      • Common NSAIDs
      • Clinical Use...
      • Side Effects...
  • Aspirin
    • The Wonder Drug...
    • PolyAspirin: The Safer and More Potent Polymer
      • Variant of Aspirin
    • Mode of Action
    • Contraindications
  • Acetaminophen
    • Acetaminophen Protects Heart Muscle
    • Acetaminophen Reduces Incidence of Ovarian Cancer
  • Ibuprofen, Ketoprofen and Naproxen
  • Combination Analgesics
    • Table 1: Opioid Analgesics Market: Percentage Share of Opioid / Acetaminophen Combination Products in the Opioid Script Volume (includes corresponding Graph/Chart)
  • OTC Analgesics: An Overview

4. INDUSTRY DYNAMICS

  • Escalating R&D Costs: A Boon or Bane?
    • Timeline of the Drug Approval Process
  • Cox II Crisis Tarnishes Industry Growth
  • Novel Therapies to Propel Opioid and Non-Opioid
    • Therapies
  • Rx-to-OTC Switch
  • Why Consumers Prefer OTC Drugs?
  • Development of Analgesic Tripeptides

5. RECENT CLINICAL TRIALS

  • PLx Initiates Clinical Trial For Aspirin-PC
  • Neurodiscovery Receives Approval for NSL-
    • Phase II Clinical Trials

6. PRODUCT INTRODUCTIONS/INNOVATIONS

  • Victory Pharma Unveils Naprelan Dose Card
  • Nutra Pharma Commences Online Sales of Cobroxin
  • Nutra Pharma to Introduce Nyloxin Rx
  • Dr Reddy' s Rolls Out Finrid
  • MIP Technologies and Supelco Introduce Unique
    • SPE Product
  • Novartis Introduces Voltaren AC Product Line
  • ProEthic Pharmaceuticals Releases Ibudone for
    • Acute Pain Management
  • Dr. Reddy' s Laboratories Introduces Supanac for Acute
    • Pain Management
  • Teva Pharmaceutical Announces the Launch of Fentanyl
    • Transdermal System
  • Dr. Reddy' s Laboratories Introduces Supanac NSAID Drug

7. PRODUCT INNOVATIONS/LAUNCHES IN RECENT PAST - A PERSPECTIVE BUILDER

  • Mallinckrodt Introduces Magnacet™ Tablets for Pain Management
  • Wockhardt to Launch New Painkiller
  • Paladin Labs and Labopharm Introduce Tridural™
  • Shionogi & Co Introduces OxiNorm Powder 0.5%
  • McNeil Brings Chewable TYLENOL® GoTabs Tablets
  • Barr Unveils Generic Version of ACTIQ®
  • Novartis Launches Voltarol Pain-Eze Emulgel.
  • TheraQuest Launches TQ-1017
  • Mentholatum Company Introduces WellPatch
    • Deep Heat Patch...

8. PRODUCT APPROVALS

  • Par Pharmaceutical Secures Approval for Marketing Tramadol ER
  • Cipher Acquires Tentative Approval for Tramadol ER Capsules
  • Lannett Receives Approval for Developing Hydromorphone Hydrochloride Tablets
  • King Pharmaceuticals Receives Approval for Embeda Pain-Relief Capsules
  • Sangart Secures EC' s Orphan Drug Designation for MP4CO
  • Biovail Secures Canadian Approval for Ralivia
  • Elite Pharmaceuticals and PharmaNetwrok Receive FDA Approval

9. RECENT INDUSTRY ACTIVITY

  • China Life Insurance Inks Agreement with Sino Biopharmaceutical
  • Azur Pharma Inks Agreement with Elan Pharmaceuticals Pfizer Acquires Wyeth
  • Taisho Pharmaceutical Takes Over OTC Drugs Business of Bristol-Myers Squibb
  • Piramal Healthcare Acquires Minrad International
  • Biocon Acquires Bulk Pharmaceuticals Unit of Hindujas
  • Abbott Acquires PG110 from PanGenetics
  • Sanofi-aventis Mexico Takes Over Laboratorios Kendrick
  • WraSer Acquires e5 Pharma' s Trezix
  • Astellas Acquires Exclusive rights to Pain-Relief Drug from Neuroges
  • Henan Lingrui Pharma Commences Construction of New Analgesic Factory
  • Labopharm Europe Enters into Agreement with Merck Sharp & Dohme
  • Cumberland Pharmaceuticals Enters into a Commercialization Agreement with DB Pharm Korea
  • Cumberland Pharmaceuticals Inks an Exclusive Agreement with Phebra
  • Mallinckrodt Acquires Rights of Exalgo Extended-Release Tablets from Neuromed
  • Labopharm Europe and Grunenthal Sign Distribution and Supply Agreement
  • Timm Medical and Ferring Co-promote Prosed DS in the US
  • Competitive Technologies and Fintrade Medical Ink Sales and Distribution Agreement
  • Accumetrics and Endotech Ink Exclusive Distribution Agreement
  • Astellas and NeurogesX Sign Distribution and Marketing Agreement
  • Akela Pharma Inks Agreement with Teikoku Seiyaku
  • Medical Nutrition Inks Exclusive Licensing Agreement with DSE Healthcare
  • Echo Therapeutics Inks a Licensing Deal with Ferndale Pharma
  • Circ Pharma Signs a Development Agreement with Elan
  • Orexo Inks Distribution Agreement with Neopharm
  • Orexo Inks Agreement with NovaMed Pharmaceuticals
  • Pharmos and Reperio Enter into Agreement
  • Caraco Pharmaceutical Launches Oxycodone Hydrochloride Tablet
  • Purdue Pharma Provides Labopharm' s RYZOLT
  • Bayer Acquires Sagmel' s OTC Business
  • E5 Pharma Receives Approval from FDA
  • Pharmaceutical Associates Receives Approval from FDA
  • Concord Receives New Drug Approvals
  • Hisamitsu Receives Approval for SALONPAs®
  • Johnson & Johnson Submits NDA to FDA
  • Nycomed and Paladin Inks Joint-Promotion Agreement for Tridural
  • Akela Extends Agreement with Janssen
  • Daiichi and Lead Chemical Receives Approval for Loxonin® Tape
  • Tokio Marine Capital Acquires Showa Yakuhin Kako
  • Corgenix Collaborates with Randox Laboratories
  • Corgenix Receives EPO Approval for Aspirin Resistance Method
  • IOL to Expand Production Capacity
  • American Oriental Bioengineering Partners with China Aoxing
  • Abraxis Takes Over Shimoda and its Subsidiary Company
  • Church & Dwight Snaps Up Del Pharmaceuticals from Coty
  • Sosei Group Corp Re-Acquires Rights to Commercialize AD 923
  • ProStrakan Group Inks Agreement with Paladin Labs
  • Anika Therapeutics Inks Distribution Agreement with DePuy Mitek
  • Wyeth Acquires ThermaCare Brand from P&G
  • Albemarle Appoints Dr. Reddy' s as Distributor of Bulk Ibuprofen API
  • Competitive Technologies and ELS Join Forces to Distribute Pain Management Device
  • Altea Therapeutics Partners with Hospira
  • Paladin Inks Co-Promotion Deal with Nycomed
  • AstraZeneca to Divest OTC Portfolio

10. CORPORTAE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER

  • Ranbaxy Receives Approval from FDA
  • Wockhardt Receives FDA Approval for DPN + APAP
  • Alpharma to Market Flector® Patch in the US
  • Auriga and Mikart Inks Agreement to Market Codein
  • Watson Receives FDA Approval for Oxycodone Hydrochloride and Ibuprofen
  • Labopharm' s Tramadol Receives Approval in Canada
  • Lion Acquires BUFFERIN® Trademark Rights
  • Grunenthal' s Extends Licensing Agreement with Ortho-McNeil
  • China Aoxing Pockets LRT
  • Anesiva Inks Joint Venture Agreement Wanbang
  • Beijing Med-Pharm Inks Agreement with Lotus Healthcare
  • LAB International Inks Licensing Agreement with Janssen Pharmaceutica
  • Three Sixty Pockets Rockford-Montgomery Labs
  • Antares Enters into License and Development Agreement for Opioid Analgesic
  • Abraxis BioScience Acquires AstraZeneca' s Analgesic Brand Portfolio
  • IntelliPharmaCeutics Inks Agreement with Larasan
  • Ranbaxy and Ethypharm Ink In-licensing Agreement
  • Elite Collaborates with TPN to Co-develop Analgesic Drug
  • Novartis Acquires Hexal Company and Major Stake in Eon Labs....
  • NovaDel Pharma Receives Patent for Buccal Sprays Technology
  • Auxilium Pharmaceuticals Enters into a Licensing Agreement with PharmaForm...
  • EC Sanctions Sale of Elan' s Prialt
  • EpiCept Corp. Merges with Maxim Pharmaceuticals, Inc
  • Reckitt Benckiser plc Acquires Boots Healthcare International...

11. FOCUS ON SELECT KEY PLAYERS

  • Bayer Consumer Care (US)
  • Johnson & Johnson (US)
    • McNeil Consumer Healthcare (Canada)
  • Novartis International AG (Switzerland)
  • Pfizer Inc. (US)
  • Reckitt Benckiser Group Plc (UK)
  • Sanofi Aventis S.A. (France)

12. GLOBAL MARKET PERSPECTIVE

  • Table 2: World Recent Past, Current & Future Analysis for Analgesics by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart)
  • Table 3: World Historic Review for Analgesics by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
  • Table 4: World 11-Year Perspective for Analgesics by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years2005,2010 & 2015(includes corresponding Graph/Chart)
  • Table 5: World Recent Past, Current & Future Analysis for Internal Analgesics by Geographic Region/ Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
  • Table 6: World Historic Review for Internal Analgesics by Geographic Region / Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
  • Table 7: World 11-Year Perspective for Internal Analgesics by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
  • Table 8: World Recent Past, Current & Future Analysis for Internal Analgesics by Product Segment - Aspirin, Acetaminophen, Ibuprofen, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart)
  • Table 9: World Historic Review for Internal Analgesics by Product Segment - Aspirin, Acetaminophen, Ibuprofen, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
  • Table 10: World 11-Year Perspective for Internal Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Aspirin, Acetaminophen, Ibuprofen, and Others Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
  • Table 11: World Recent Past, Current & Future Analysis for Aspirin by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart)
  • Table 12: World Historic Review for Aspirin by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
  • Table 13: World 11-Year Perspective for Aspirin by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005,2010& 2015 (includes corresponding Graph/Chart)
  • Table 14: World Recent Past, Current & Future Analysis for Acetaminophen by Geographic Region/ Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart)
  • Table 15: World Historic Review for Acetaminophen by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
  • Table 16: World 11-Year Perspective for Acetaminophen by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005,2010 & 2015 (includes corresponding Graph/Chart)
  • Table 17: World Recent Past, Current & Future Analysis for Ibuprofen by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart)
  • Table 18: World Historic Review for Ibuprofen by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
  • Table 19: World 11-Year Perspective for Ibuprofen by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005,2010 & 2015 (includes corresponding Graph/Chart)
  • Table 20: World Recent Past, Current & Future Analysis for Other Internal Analgesics by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart)
  • Table 21: World Historic Review for Other Internal Analgesics by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
  • Table 22: World 11-Year Perspective for Other Internal Analgesics by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years2005,2010 & 2015 (includes corresponding Graph/Chart)
  • Table 23: World Recent Past, Current & Future Analysis for External Analgesics by Geographic Region/ Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 2015 (includes corresponding Graph/Chart)
  • Table 24: World Historic Review for External Analgesics by Geographic Region / Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2007 (includes corresponding Graph/Chart)
  • Table 25: World 11-Year Perspective for External Analgesics by Geographic Region /Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years2005,2010 & 2015(includes corresponding Graph/Chart)

13. THE UNITED STATES

  • A. Market Analysis
    • Current and Future Analysis
    • Pain Statistics in the US
    • Industry Overview
      • Internal Analgesics
        • Cox-2 Drugs in for Some Trouble
        • Switch to OTC Drugs
          • Table 26: US Analgesics Market (2009): Percentage Share Breakdown of Leading Manufacturers by Sales (includes corresponding Graph/Chart)
          • Table 27: US Internal Liquid Analgesics Market (2009): Percentage Share Breakdown of Leading Brands by Sales (includes corresponding Graph/Chart)
          • Table 28: US Internal Tablet Analgesics Market (2009): Percentage Share Breakdown of Leading Brands by Sales (includes corresponding Graph/Chart)
          • Table 29: Internal Analgesics Market in the US by Retail Channel (2008): Percentage Share by Value Sales for Discount Stores, Food/Drug Combination Stores, Chain Drug Stores, Supermarkets, and Independent Drug Stores (includes corresponding Graph/Chart)
        • Promotional Strategies for the Internal Analgesics
          • Table 30: Market for Internal Liquid Analgesics in the U.S. by Retail Channel (2008): Percentage Share by Value Sales for Supermarkets, Drug Stores, and Discounters (includes corresponding Graph/Chart)
        • Pediatric Analgesics: The New Kid on the Block
      • External Analgesics
        • Stretching Boundaries
          • Table 31: US External Analgesics Market (2007): Percentage Share Breakdown of Leading Ten Brands by Revenues (includes corresponding Graph/Chart)
          • Table 32: External Analgesics Market in the US by Retail Channel (2008): Percentage Share by Value Sales for Chain drug stores, Discount stores, Food/drug combination stores, Independent drug stores, and Supermarkets (includes corresponding Graph/Chart)
        • Rubs, Patches: Driving the External Analgesics Market
        • Patch Relief...Gaining Momentum
  • B. Market Analytics
    • Table 33: US Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 34: US Historic Review for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 35: US 11-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for2005,2010 & 2015(includes corresponding Graph/Chart)

14. CANADA

  • Market Analysis
    • Table 36: Canadian Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart)
    • Table 37: Canadian Historic Review for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 38: Canadian 11-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for2005,2010 & 2015(includes corresponding Graph/Chart)

15. JAPAN

  • A. Market Analysis
    • Current and Future Analysis
    • Competitive Scenario in the Past
      • Table 39: OTC Analgesics Market in Japan (2005): Market Share of Leading Players by Value - Lion, Arax, Taisho Pharmaceutical, SS Pharmaceutical, Shionogi, and Others (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 40: Japanese Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart)
    • Table 41: Japanese Historic Review for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 42: Japanese 11-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for2005,2010 & 2015 (includes corresponding Graph/Chart)

16. EUROPE

  • A. Market Analysis
    • Current and Future Analysis
      • By Product Group/Segment
    • European Pain Management Market
    • Generics Restrain Revenue Growth
    • Popular Brands in 2004
      • Table 43: Popular Brands of Pain & Inflammation Medication in Europe (2004): Percentage Share of Aspirin, Voltaren, Ibuprofen, Nurofen, Vioxx, Celebre, Tylenol, Aulin, Anadin, and Paracetamol (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 44: European Recent Past, Current & Future Analysis for Analgesics by Geographic Region/Country - France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart)
    • Table 45: European Historic Review for Analgesics by Geographic Region/Country - France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 46: European 11-Year Perspective for Analgesics by Geographic Region/Country - Percentage Breakdown of Dollar Sales for France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
    • Table 47: European Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 48: European Historic Review for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2007 (includes corresponding Graph/Chart)
    • Table 49: European 11-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)

16a. FRANCE

  • A. Market Analysis
    • Current and Future Analysis
    • Competitive Scenario
      • Table 50: Analgesics Market in France (2005): Market Share of Leading Players by Value - Bristol-Myers Squibb, Therapix, Roche, Bayer Group, Wyeth Consumer Healthcare, and Others) (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 51: French Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart)
    • Table 52: French Historic Review for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 53: French 11-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for2005,2010 & 2015(includes corresponding Graph/Chart)

16b. GERMANY

  • A. Market Analysis
    • Current and Future Analysis
    • Competitive Scenario
      • Table 54: Analgesics Market in Germany (2005): Market Share of Leading Players by Value - Bayer Group, Boehringer Ingelheim, Wyeth Consumer Healthcare, and Others (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 55: German Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart)
    • Table 56: German Historic Review for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 57: German 11-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for2005,2010 & 2015(includes corresponding Graph/Chart)

16c. ITALY

  • A. Market Analysis
    • Current and Future Analysis
    • Competitive Scenario
      • Table 58: Analgesics Market in Italy (2005): Market Share of Leading Players by Value - Bayer Group, Angelini, Novartis, Bristol-Myers Squibb, and Others (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 59: Italian Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart)
    • Table 60: Italian Historic Review for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 61: Italian 11-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for2005,2010 & 2015 (includes corresponding Graph/Chart)

16d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current and Future Analysis
    • An Overview of Analgesics Market in the UK
      • Distribution Scenario
    • Competitive Scenario
      • Table 62: Analgesics Market in the United Kingdom (2005E): Market Shares of Leading Players by Value - Boots Healthcare, GlaxoSmithKline, and Others (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 63: UK Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 64: UK Historic Review for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 65: UK 11-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for 2005,2010 & 2015(includes corresponding Graph/Chart)

16e. SPAIN

  • A. Market Analysis
    • Current and Future Analysis
    • Competitive Scenario
      • Table 66: Analgesics Market in Spain (2005): Market Share of Leading Players by Value - Bayer Group, Boehringer Ingelheim, Bristol-Myers Squibb, Novartis, Boots Healthcare, and Others (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 67: Spanish Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 68: Spanish Historic Review for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006(includes corresponding Graph/Chart)
    • Table 69: Spanish 11-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for2005,2010 & 2015 (includes corresponding Graph/Chart)

16f. REST OF EUROPE

  • Market Analysis
    • Table 70: Rest of Europe Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart)
    • Table 71: Rest of Europe Historic Review for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 72: Rest of Europe 11-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)

17. ASIA-PACIFIC

  • A. Market Analysis
    • Current and Future Analysis
    • The OTC Analgesic Market
      • OTC Analgesics Market in Asia-Pacific (2004):
        • A Comparative Analysis of the Major Regions -
          • Australia, China and South Korea
  • B. Market Analytics
    • Table 73: Asia-Pacific Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart)
    • Table 74: Asia-Pacific Historic Review for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 75: Asia-Pacific 11-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for 2005,2010 & 2015(includes corresponding Graph/Chart)

18. LATIN AMERICA

  • Market Analysis
    • Table 76: Latin American Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 77: Latin American Historic Review for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 78: Latin American 11-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for 2005, 2010 & 2015(includes corresponding Graph/Chart)

19. REST OF WORLD

  • Market Analysis
    • Table 79: Rest of World Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 80: Rest of World Historic Review for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 81: Rest of World 11-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for 2005, 2010 & 2015 includes corresponding Graph/Chart)

20. APPENDIX - POPULAR ANALGESIC BRANDS BY REGION

  • Canada
  • France
  • Germany
  • United Kingdom
  • Leading Analgesics Brands for Children
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Latin America

COMPETITION

Back to Top